Screening of metabolic markers related to molecular typing of breast cancer based on 1H NMR metabonomics
This study demonstrates pronounced metabolic differences across BC subtypes that mirror their distinct molecular profiles and may underlie variations in therapeutic response. These metabolomic insights hold promise for refining tumor classification, improving diagnostic accuracy and guiding more personalized treatment strategies.
Authors
- Zhuan Hong
- Weixiao Ke (ORCID: https://orcid.org/0000-0002-3159-672X)
- Yongcheng Zhang (ORCID: https://orcid.org/0000-0002-0563-0568)
- Xinping Huang
- Man Xu
- Yongxia Yang
- Hailong Shu
Institutions
- Guangdong Pharmaceutical University (CN)
- First Affiliated Hospital of Guangdong Pharmaceutical University (CN)
- Traditional Chinese Medicine Bureau of Guangdong Province (CN)
Publication Details
- Journal
- Advances in Clinical and Experimental Medicine
- Published
- 2026-01-12
- DOI
- https://doi.org/10.17219/acem/204347
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province